Beckwith-Wiedemann Syndrome Research Grant supports researchers studying the condition through scientific and clinical work to improve diagnosis, understand disease mechanisms, and advance therapies.
Funder: National Organization for Rare Disorders
Due Dates: January 19, 2027, at 11:59 p.m. PT (Initial application / Letter of Intent) | March 2027 (Full proposal invitations) | June 2027 (Award announcements)
Funding Amounts: One grant up to $50,000 USD for a one- or two-year project
Summary: Supports scientific and clinical research on Beckwith-Wiedemann syndrome to improve diagnosis, understand disease mechanisms, and advance therapies.
Key Information: Strong preference for faculty-level or senior scientific researchers at academic or nonprofit institutions or foundations.
The National Organization for Rare Disorders (NORD), with donations from the Beckwith-Wiedemann Syndrome Community, supports scientific and clinical studies related to Beckwith-Wiedemann syndrome through its Rare Disease Research Grants Program. The syndrome is an overgrowth and cancer predisposition disorder involving changes affecting growth-controlling genes in chromosome region 11p15.5, with symptoms that vary widely in severity.
The grant provides seed funding to initiate research studies or clinical trials that improve diagnosis, clarify underlying disease mechanisms, or advance therapy. Ideally, the work will have potential to lead to a new or better therapy. Results may also help investigators secure further support from the NIH, FDA, other funding agencies, or a corporate sponsor.